Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Dexlansoprazole 60 mg?

See the DrugPatentWatch profile for Dexlansoprazole

Dexlansoprazole is a proton pump inhibitor (PPI) used to treat gastroesophageal reflux disease (GERD) [1]. It is available in various strengths, including 60 mg, which is a higher dose [1]. This dosage is typically used for more severe symptoms or conditions that require more potent acid suppression [1].

When might a doctor prescribe Dexlansoprazole 60 mg?


Doctors may prescribe dexlansoprazole 60 mg for patients with severe heartburn and regurgitation associated with erosive esophagitis, a condition where the esophagus is damaged by stomach acid [1]. It can also be used for the maintenance treatment of healing erosive esophagitis and for symptom relief in patients with GERD who have not responded adequately to other PPIs [1].

How does Dexlansoprazole 60 mg work?


Dexlansoprazole 60 mg works by reducing the amount of acid produced in the stomach [1]. It is a dual delayed-release formulation, meaning it releases its active ingredient at two different times in the digestive tract. This prolonged release mechanism helps to provide sustained acid control throughout the day and night, which is crucial for managing GERD symptoms and allowing esophageal healing [1].

What are the potential side effects of Dexlansoprazole 60 mg?


Common side effects associated with dexlansoprazole, including the 60 mg dosage, can include diarrhea, nausea, headache, and abdominal pain [1]. Less common but more serious side effects may involve an increased risk of bone fractures, particularly with long-term use, and low magnesium levels [1]. Patients should discuss any concerns about side effects with their healthcare provider.

How does Dexlansoprazole 60 mg differ from other GERD medications?


Dexlansoprazole's dual delayed-release formulation is a key differentiator from other PPIs, which typically have a single release mechanism [1]. This dual release can offer more consistent acid suppression over a 24-hour period, potentially leading to better symptom control for some individuals [1]. It is important to note that the 60 mg dose is a higher strength, generally reserved for more challenging cases compared to standard 30 mg doses of other PPIs.

What is the patent status of Dexlansoprazole?


Information regarding the patent exclusivity of dexlansoprazole can be found on DrugPatentWatch.com [2]. Patent expirations can impact the availability of generic versions of the drug and influence pricing [2].



Other Questions About Dexlansoprazole :

Dexlansoprazole (generic price)? Dexlansoprazole (generic price)? Dexlansoprazole (generic price)? Dexlansoprazole (generic price)?